Our Solutions

Outsourcing-Pharma: Altasciences Eyes Early Development Space, CDMO Addition

Altasciences eyes early development space, CDMO addition

 By Melissa Fassbender

Consolidating its businesses under one brand, Altasciences is transitioning to an early drug development CRO – and looking to add a CDMO to manufacture drugs up to Phase II volumes.

HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2019/02/26/ALTASCIENCES-EYES-EARLY-DEVELOPMENT-SPACE-CDMO-ADDITION